scispace - formally typeset
R

Richard N. Bergman

Researcher at Cedars-Sinai Medical Center

Publications -  489
Citations -  97005

Richard N. Bergman is an academic researcher from Cedars-Sinai Medical Center. The author has contributed to research in topics: Insulin & Insulin resistance. The author has an hindex of 130, co-authored 477 publications receiving 91718 citations. Previous affiliations of Richard N. Bergman include University of Southern California & University of California, Los Angeles.

Papers
More filters
Journal ArticleDOI

Influence of total vs. visceral fat on insulin action and secretion in African American and white children.

TL;DR: Body fat in general is the predominant factor influencing Si, but VFAT may have additional effects on fasting insulin, and the lack of major effects of VfAT on Si in children may be explained by lower levels of VFatin or because VFat affects aspects of whole body insulin action that are not measured by the minimal model.
Journal ArticleDOI

Effects of Insulin-Like Growth Factor I (IGF-I) Therapy on Body Composition and Insulin Resistance in IGF-I Gene Deletion

TL;DR: In this patient with severe insulin resistance, therapy with rhIGF-I resulted in beneficial effects on Si, body composition, bone size, and linear growth, which have implications for IGF-I therapy in a variety insulin resistant states.
Journal ArticleDOI

Minimal Model-Based Insulin Sensitivity Has Greater Heritability and a Different Genetic Basis Than Homeostasis Model Assessment or Fasting Insulin

TL;DR: In this article, the authors compare sensitivity from the minimal model (insulin sensitivity index [S(I)]) with the measure of insulin resistance emanating from the homeostasis model assessment (HOMA) approach.